Client News
Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients
1st June 2023
Carbios will receive grants totaling €54 million from French State via France 2030 and Grand-Est Region[1] to finance construction of world’s first PET biorecycling plant and accelerate R&D activities
31st May 2023
Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials
31st May 2023
Destiny Pharma: Board Changes Dr Debra Barker Appointed Interim CEO
25th May 2023
ONWARD: Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury
25th May 2023
Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper
24th May 2023
Medigene AG: Medigene Expands Patent Portfolio for its End-to-End Platform
22nd May 2023
MIG Capital: MIG Capital strengthens its investment team with four new professionals
17th May 2023
There is no more content to load